The dawn of the liquid biopsy in the fight against cancer

Cancer is a molecular disease associated with alterations in the genome, which, thanks to the highly improved sensitivity of mutation detection techniques, can be identified in cell-free DNA (cfDNA) circulating in blood, a method also called liquid biopsy. This is a non-invasive alternative to surgi...

Descripción completa

Detalles Bibliográficos
Autores principales: Domínguez-Vigil, Irma G., Moreno-Martínez, Ana K., Wang, Julia Y., Roehrl, Michael H.A., Barrera-Saldaña, Hugo A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788692/
https://www.ncbi.nlm.nih.gov/pubmed/29416824
http://dx.doi.org/10.18632/oncotarget.23131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788692/
https://www.ncbi.nlm.nih.gov/pubmed/29416824
http://dx.doi.org/10.18632/oncotarget.23131

Ejemplares similares